Cadila Healthcare Gets US FDA Approvals For Three Products (Nasdaq)
(RTTNews) - Tuesday, Cadila Healthcare announced that the company is in receipt of three US FDA approvals for marketing Benzonatate tablets in the strength of 100mg and 200mg, Naproxen tablets and tentative approval for Amlodipine Besylate tablets 2.5mg, 5mg, and 10 mg.

India, China Major Suppliers of Drugs to U.S., Though Quality-Control Slim (The Daily News)
WASHINGTON -- India and China, countries where the Food and Drug Administration rarely conducts quality-control inspections, have become major suppliers of low-cost drugs and drug ingredients to American consumers. Analysts say their products are becoming pervasive in the generic and over-the-counter marketplace.